Prospective Monitoring of Antibody Response Following COVID-19 Vaccination in Patients With Down Syndrome
Latest Information Update: 07 Dec 2023
At a glance
- Drugs AZD 1222 (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Acronyms PRIDE
- 24 Jun 2022 Results assessing antibody response after two mRNA vaccinations or after two ChAdOx1 vaccination published in the Journal of Infectious Diseases
- 08 Dec 2021 New trial record